Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-20-065103

President sold 45,000 shares at an average $62.47 ($2,810,983)

  • President acquired 45,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
RUBINSTEIN JULIE President 2020-12-21 Option exercise +15,000 $6.32 $94,800 15,000 D
RUBINSTEIN JULIE President 2020-12-21 Sale −7,677 $59.15 $454,095 7,323 D
RUBINSTEIN JULIE President 2020-12-21 Sale −7,323 $59.72 $437,330 0 D
RUBINSTEIN JULIE President 2020-12-22 Option exercise +15,000 $6.32 $94,800 15,000 D
RUBINSTEIN JULIE President 2020-12-22 Sale −13,100 $63.62 $833,422 1,900 D
RUBINSTEIN JULIE President 2020-12-22 Sale −1,900 $64.36 $122,284 0 D
RUBINSTEIN JULIE President 2020-12-23 Option exercise +15,000 $6.32 $94,800 15,000 D
RUBINSTEIN JULIE President 2020-12-23 Sale −8,465 $63.90 $540,914 6,535 D
RUBINSTEIN JULIE President 2020-12-23 Sale −5,506 $64.59 $355,633 1,029 D
RUBINSTEIN JULIE President 2020-12-23 Sale −1,029 $65.41 $67,307 0 D
Derivatives
RUBINSTEIN JULIE President 2020-12-21 Option exercise · Stock Option (Right to Buy) −15,000 485,000 D
RUBINSTEIN JULIE President 2020-12-22 Option exercise · Stock Option (Right to Buy) −15,000 470,000 D
RUBINSTEIN JULIE President 2020-12-23 Option exercise · Stock Option (Right to Buy) −15,000 455,000 D
Open-market sales · 45,000 sh · avg $62.47 · $2,810,983
Loading xslF345X03/doc4.xml…